While D-Wave Quantum Inc. QBTS focuses on quantum computing solutions with AI applications, Accenture ACN tries to disrupt ...

Neurological disorders, including Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis, pose significant challenges due to their complex pathophysiology ...

In 2025, pharmacy leaders are grappling with a billion-dollar question: how to deliver high-quality, patient-centered care amid financial strain, policy uncertainty, and rapid technological change.

Selected in the bioprocessing category, Dr. Narain is honored for his pioneering work at the intersection of biology, AI, and translational medicine. Under his leadership, BPGbio has focused on ...

Intellomx announces its' new Pilot platform, delivering rapid identification of novel drugs arising from its therapeutic ...

The global biosimulation market, valued at approximately USD 3.1 billion in 2022, is on track to experience significant growth over the next decade. Projected to expand at a compound annual growth ...

Pharmaceutical industry experts at Gitex Asia 2025 discuss how AI is revolutionising drug discovery, from accelerating ...

Eric Schmidt’s AI predictions reveal a future of innovation, risks, and ethical dilemmas. Are we ready for the rise of ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

At Argonne National Laboratory near Chicago researchers are using AI and high performance computing to develop new methods ...

Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its ...